BN Business News
Add your company to Business Communicator →

Business · 10/08/2010Updated: 10/17/2026 · 1 min read

FDA Clears Way for Nandrolone Decanoate Injection to be Used for New Drug Applications

Summary

The FDA has determined that DECA-DURABOLIN injection, 200 mg/mL, 1 mL, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for the approval of abbreviated new drug applications for this formulation.

Original source language: Federal Register — Health and Human ServicesOpen original release →

Explore insights

Business insights →